155 related articles for article (PubMed ID: 16761358)
1. Inflammatory breast cancer: current concepts in local management.
Bristol IJ; Buchholz TA
Breast Dis; 2005-2006; 22():75-83. PubMed ID: 16761358
[TBL] [Abstract][Full Text] [Related]
2. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer.
Bristol IJ; Woodward WA; Strom EA; Cristofanilli M; Domain D; Singletary SE; Perkins GH; Oh JL; Yu TK; Terrefe W; Sahin AA; Hunt KK; Hortobagyi GN; Buchholz TA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):474-84. PubMed ID: 18439768
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.
Fleming RY; Asmar L; Buzdar AU; McNeese MD; Ames FC; Ross MI; Singletary SE
Ann Surg Oncol; 1997 Sep; 4(6):452-61. PubMed ID: 9309333
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast cancer.
Lopez MJ; Porter KA
Surg Clin North Am; 1996 Apr; 76(2):411-29. PubMed ID: 8610272
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatments for inflammatory breast cancer.
Yang CH; Cristofanilli M
Breast Dis; 2005-2006; 22():55-65. PubMed ID: 16735787
[TBL] [Abstract][Full Text] [Related]
6. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
7. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
Sawaki M; Ito Y; Akiyama F; Tokudome N; Horii R; Mizunuma N; Takahashi S; Horikoshi N; Imai T; Nakao A; Kasumi F; Sakamoto G; Hatake K
Breast Cancer; 2006; 13(2):172-8. PubMed ID: 16755113
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated course of radiotherapy (RT) for breast cancer.
Schoenfeld JD; Harris JR
Breast; 2011 Oct; 20 Suppl 3():S116-27. PubMed ID: 22015277
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
Liauw SL; Benda RK; Morris CG; Mendenhall NP
Cancer; 2004 Mar; 100(5):920-8. PubMed ID: 14983486
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
12. A single-center experience with inflammatory breast cancer, 1985-2003.
Smoot RL; Koch CA; Degnim AC; Sterioff S; Donohue JH; Grant CS; Barnes SA; Gullerud RE; Hobday TJ; Farley DR
Arch Surg; 2006 Jun; 141(6):567-72; discussion 572-3. PubMed ID: 16785357
[TBL] [Abstract][Full Text] [Related]
13. Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Harris EE; Schultz D; Bertsch H; Fox K; Glick J; Solin LJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1200-8. PubMed ID: 12654428
[TBL] [Abstract][Full Text] [Related]
14. [Breast cancer treatment].
Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
[No Abstract] [Full Text] [Related]
15. Phase II study on breast conservative surgery plus chemo- and radiotherapy in treating Chinese patients with early staged breast cancer.
Liu YC; Zhou SB; Gao F; Yin XX; Zhao Y; Huang XE
Asian Pac J Cancer Prev; 2013; 14(6):3747-50. PubMed ID: 23886176
[TBL] [Abstract][Full Text] [Related]
16. [Role of radiotherapy in the management of adenocarcinoma of the breast accessible to conservative surgery].
Romestaing P; Mazeron JJ; Coquard R; Ardiet JM; Mornex F; Gérard JP
Cancer Radiother; 1997; 1(1):14-28. PubMed ID: 9265530
[TBL] [Abstract][Full Text] [Related]
17. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Ueno NT; Buzdar AU; Singletary SE; Ames FC; McNeese MD; Holmes FA; Theriault RL; Strom EA; Wasaff BJ; Asmar L; Frye D; Hortobagyi GN
Cancer Chemother Pharmacol; 1997; 40(4):321-9. PubMed ID: 9225950
[TBL] [Abstract][Full Text] [Related]
18. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
19. Surgical aspects of inflammatory breast cancer.
Kell MR; Morrow M
Breast Dis; 2005-2006; 22():67-73. PubMed ID: 16735788
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
